Ordinary Index Rebalancing in the Solactive Diabetes Performance-Index | March 2022
In the ordinary rebalance the following composition will be implemented effective open 14.03.2022:
| ELI LILLY & CO |
| ABBOTT LABORATORIES |
| NOVO NORDISK A/S |
| DEXCOM INC |
| INSULET CORP |
| TANDEM DIABETES CARE INC |
| CONVATEC GROUP PLC |
| YPSOMED HOLDING AG |
| SENSEONICS HOLDINGS INC |
| MANNKIND CORP |
| LEXICON PHARMACEUTICALS INC |
| ORAMED PHARMACEUTICALS INC |
| EKF DIAGNOSTICS HOLDINGS PLC |
| PROVENTION BIO INC |
| KALVISTA PHARMACEUTICALS INC |
| OPTHEA LTD |
| SERNOVA CORP |
| DARIOHEALTH CORP |